Clinical Trials Logo
  1. Home
  2. Disease-Free Survival
  3. NCT03504449

Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial — SCRM-01  

Disease-free Survival Clinical Trial

Clinical Trial Summary

For now, neoadjuvant chemoradiotherapy is routinely performed for T3N1-2M0 rectal cancer. However, there are lots of complications following neoadjuvant chemoradiotherapy, such as Wound-related complications, anastomotic leakage, anastomotic stenosis, sexual dysfunction, testicular or ovary failure. Patients undergoing resection for rectal cancer had low rates of local recurrence and long disease-free survival regardless of whether an APR, CAA or low AR was performed. The main purpose of preoperative radiotherapy is to lower the local recurrence. For the T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, we suppose might not necessary to receive neoadjuvant chemoradiotherapy, for operation can achieve the negative circumferential resection margin.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03504449
Study type Interventional
Source Beijing Chao Yang Hospital
Contact Jiagang Han, MD
Phone +861085231604
Email wzhj611@163.com
Status Recruiting
Phase N/A
Start date December 1, 2016
Completion date December 1, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT03923400 - Jejunoileal vs Gastric GIST in the Era of Imatinib.
Completed NCT00748358 - An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer Phase 2
Completed NCT02980185 - Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer N/A
Recruiting NCT03967457 - Comprehensive Study on the Quality of Life in Cervical Cancer Patients
Recruiting NCT05436561 - Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies Phase 2
Not yet recruiting NCT01236989 - Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC N/A
Not yet recruiting NCT03423849 - The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy Phase 2/Phase 3
Active, not recruiting NCT04947020 - dataBase for Analysis of Rectal Cancer Oncological Results